Enhancer ID: | E_01_0242 |
Species: | human |
Position : | chr11:35136216-35138216 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Lung adenocarcinoma |
Pubmed ID: | 31583122 |
Enhancer experiment: | PCR,Western blot |
Enhancer experiment description: | It has been suggested that the expression of stem cell-associated markers, such as CD44 and Oct4, may support their roles in therapy evasion, tumor recur_x0002_rence, and metastasis11. |
Target gene : | CD44 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | It has been suggested that the expression of stem cell-associated markers, such as CD44 and Oct4, may support their roles in therapy evasion, tumor recur_x0002_rence, and metastasis11. |
TF name : | -- |
TF experiment: | PCR,Western blot |
TF experiment description: | It has been suggested that the expression of stem cell-associated markers, such as CD44 and Oct4, may support their roles in therapy evasion, tumor recur_x0002_rence, and metastasis11. |
Enhancer function : | It has been suggested that the expression of stem cell-associated markers, such as CD44 and Oct4, may support their roles in therapy evasion, tumor recur_x0002_rence, and metastasis11. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
It has been suggested that the expression of stem cell-associated markers, such as CD44 and Oct4, may support their roles in therapy evasion, tumor recur_x0002_rence, and metastasis11. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|